Lars Erik Bryld

1.8k total citations
34 papers, 1.3k citations indexed

About

Lars Erik Bryld is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Lars Erik Bryld has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Dermatology, 16 papers in Immunology and 8 papers in Immunology and Allergy. Recurrent topics in Lars Erik Bryld's work include Dermatology and Skin Diseases (15 papers), Psoriasis: Treatment and Pathogenesis (15 papers) and Contact Dermatitis and Allergies (12 papers). Lars Erik Bryld is often cited by papers focused on Dermatology and Skin Diseases (15 papers), Psoriasis: Treatment and Pathogenesis (15 papers) and Contact Dermatitis and Allergies (12 papers). Lars Erik Bryld collaborates with scholars based in Denmark, United States and Switzerland. Lars Erik Bryld's co-authors include Lone Skov, Tove Agner, Robert Gniadecki, Lars Iversen, Alexander Egeberg, Kirsten Ohm Kyvik, Torkil Menné, Charlotte Hindsberger, Mads Kirchheiner Rasmussen and B K Bang and has published in prestigious journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Lars Erik Bryld

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by Lars Erik Bryld

Since Specialization

Citations

This map shows the geographic impact of Lars Erik Bryld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Erik Bryld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Erik Bryld more than expected).

Fields of papers citing papers by Lars Erik Bryld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Erik Bryld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Erik Bryld. The network helps show where Lars Erik Bryld may publish in the future.

Co-authorship network of co-authors of Lars Erik Bryld

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Erik Bryld. A scholar is included among the top collaborators of Lars Erik Bryld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Erik Bryld. Lars Erik Bryld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study 2023 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Mads Kirchheiner Rasmussen, Trine Bertelsen, Tomas Norman Dam, Lone Skov, Lars Erik Bryld, Jashin J. Wu, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg	5
2	Drug survival of biologic therapies for palmoplantar pustulosis: A nationwide study 2023 ·Journal of the European Academy of Dermatology and Venereology ·Trine Bertelsen, Alexander Egeberg, Lone Skov, Mads Kirchheiner Rasmussen, Lars Erik Bryld, Anne T. Funding, (unknown), (unknown)	1
3	Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study 2023 ·Journal of Investigative Dermatology ·(unknown), (unknown), Julia‐Tatjana Maul, Jashin J. Wu, Lone Skov, Lars Erik Bryld, Mads Kirchheiner Rasmussen, (unknown), Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg	10
4	Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study 2023 ·Acta Dermato Venereologica ·Nikolai Loft, Alexander Egeberg, (unknown), Mads Kirchheiner Rasmussen, Lars Erik Bryld, Tomas Norman Dam, (unknown), Trine Bertelsen, Lone Skov	3
5	Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries 2022 ·Seminars in Arthritis and Rheumatism ·Alexander Egeberg, (unknown), (unknown), (unknown), (unknown), (unknown), Lars Erik Kristensen, Jacob P. Thyssen, Simon Francis Thomsen, René Cordtz, Nikolai Loft, Lone Skov, Lars Erik Bryld, Mads Kirchheiner Rasmussen, Pil Højgaard, Salome Kristensen, Lene Dreyer	57
6	Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis 2019 ·Journal of the American Academy of Dermatology ·Alexander Egeberg, Lars Erik Bryld, Lone Skov	54
7	Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study 2019 ·Acta Dermato Venereologica ·Nikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, Lars Erik Bryld, Robert Gniadecki, T Dam, Lars Iversen, Lone Skov	21
8	Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study 2015 ·Journal of the European Academy of Dermatology and Venereology ·Ole Ahlehoff, Peter Riis Hansen, Gunnar Gislason, Martin Frydland, Lars Erik Bryld, Hanne Elming, Gregor B. E. Jemec	33
9	Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort 2014 ·Journal of the European Academy of Dermatology and Venereology ·Ole Ahlehoff, Lone Skov, Gunnar Gislason, Robert Gniadecki, Lars Iversen, Lars Erik Bryld, (unknown), Jesper Lindhardsen, Søren Lund Kristensen, Christian Torp‐Pedersen, Peter Riis Hansen	148
10	Recurrent Boils of the Axilla and Groin: A Quiz 2012 ·Acta Dermato Venereologica ·Kristina Sophie Ibler, Lars Erik Bryld, (unknown), Gregor B. E. Jemec	1
11	Teledermatology with an integrated nurse – led clinic on the Faroe Islands – 7 years’ experience 2010 ·Journal of the European Academy of Dermatology and Venereology ·Lars Erik Bryld, Michael Heidenheim, T.N. Dam, (unknown), (unknown), Tove Agner, Gregor B. E. Jemec	11
12	Hidradenitis Suppurativa Complicating Naevus Comedonicus: The Possible Influence of Mechanical Stress on the Development of Hidradenitis Suppurativa 2010 ·Dermatology ·D Dufour, Lars Erik Bryld, Gregor B. E. Jemec	32
13	Heritability of Hand Eczema Is Not Explained by Comorbidity with Atopic Dermatitis 2007 ·Journal of Investigative Dermatology ·Anne Lerbæk, Kirsten Ohm Kyvik, Jakob Mortensen, Lars Erik Bryld, Torkil Menné, Tove Agner	63
14	Genetic factors in nickel allergy evaluated in a population based female twin sample 2004 ·British Journal of Dermatology ·Lars Erik Bryld, Charlotte Hindsberger, Kirsten Ohm Kyvik, Tove Agner, Torkil Menné	1
15	Genetic Factors in Nickel Allergy Evaluated in a Population-Based Female Twin Sample 2004 ·Journal of Investigative Dermatology ·Lars Erik Bryld, Charlotte Hindsberger, Kirsten Ohm Kyvik, Tove Agner, Torkil Menné	32
16	Relation Between Vesicular Eruptions on the Hands and Tinea Pedis, Atopic Dermatitis and Nickel Allergy 2003 ·Acta Dermato Venereologica ·Lars Erik Bryld, Tove Agner, Torkil Menné	38
17	Risk factors influencing the development of hand eczema in a population-based twin sample 2003 ·British Journal of Dermatology ·Lars Erik Bryld, Charlotte Hindsberger, Kirsten Ohm Kyvik, Tove Agner, T Menné	129
18	Allergic contact dermatitis from 3‐iodo‐2‐propynyl‐butylcarbamate (IPBC) – an update 2001 ·Contact Dermatitis ·Lars Erik Bryld, Tove Agner, Torkil Menné	27
19	A genetic-epidemiological study of hand eczema in young adult twins 2000 ·Lars Erik Bryld	6
20	Airborne Contact Dermatitis From Coleus Plant 1997 ·American Journal of Contact Dermatitis ·Lars Erik Bryld	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact